MAGI2 hypermethylation disrupts Wnt/β‐catenin signaling, promoting tumor invasiveness [23], while HAND2 hypermethylation impairs progesterone signaling, contributing to hormone therapy resistance [24]. This evidence concerns the gene HAND2 and neoplasm.